Viking Global Investors Lp - Net Worth and Insider Trading
Viking Global Investors Lp Net Worth
The estimated net worth of Viking Global Investors Lp is at least $5.0 Billion dollars as of 2024-05-23. Viking Global Investors Lp is the 10% Owner of Myovant Sciences Ltd and owns about 40,765,599 shares of Myovant Sciences Ltd (MYOV) stock worth over $1.1 Billion. Viking Global Investors Lp is the 10% Owner of APi Group Corp and owns about 27,032,516 shares of APi Group Corp (APG) stock worth over $977 Million. Viking Global Investors Lp is also the 10% Owner of Roivant Sciences Ltd and owns about 75,238,700 shares of Roivant Sciences Ltd (ROIV) stock worth over $839 Million. Besides these, Viking Global Investors Lp also holds BridgeBio Pharma Inc (BBIO) , RayzeBio inc (RYZB) , Urovant Sciences Ltd (UROV) , Inhibrx Inc (INBX) , 4D Molecular Therapeutics Inc (FDMT) , Adaptive Biotechnologies Corp (ADPT) , FIGS Inc (FIGS) , Zentalis Pharmaceuticals Inc (ZNTL) , PROCEPT BioRobotics Corp (PRCT) , Frazier Lifesciences Acquisition Corp (FLAC) , Rallybio Corp (RLYB) , Sio Gene Therapies Inc (SIOX) , Amylyx Pharmaceuticals Inc (AMLX) . Details can be seen in Viking Global Investors Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Viking Global Investors Lp has not made any transactions after 2024-03-05 and currently still holds the listed stock(s).
Transaction Summary of Viking Global Investors Lp
Viking Global Investors Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Viking Global Investors Lp owns 22 companies in total, including Inhibrx Inc (INBX) , APi Group Corp (APG) , and Zentalis Pharmaceuticals Inc (ZNTL) among others .
Click here to see the complete history of Viking Global Investors Lp’s form 4 insider trades.
Insider Ownership Summary of Viking Global Investors Lp
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
INBX | Inhibrx Inc | 2023-08-28 | 10 percent owner |
APG | APi Group Corp | 2024-03-05 | 10 percent owner |
ZNTL | Zentalis Pharmaceuticals Inc | 2020-12-01 | 10 percent owner |
2020-12-14 | 10 percent owner | ||
2016-07-08 | 10 percent owner | ||
2019-03-18 | 10 percent owner | ||
2019-06-04 | 10 percent owner | ||
2019-07-10 | other: Former 10% Owner | ||
2023-07-18 | 10 percent owner | ||
2016-04-13 | 10 percent owner | ||
2016-02-02 | 10 percent owner | ||
2014-10-01 | 10 percent owner | ||
2022-03-18 | 10 percent owner | ||
2023-06-22 | 10 percent owner | ||
2024-01-04 | 10 percent owner | ||
2022-09-09 | 10 percent owner | ||
2022-11-15 | 10 percent owner | ||
2022-03-02 | 10 percent owner | ||
2021-09-03 | 10 percent owner | ||
2022-11-02 | 10 percent owner | ||
2022-11-01 | 10 percent owner | ||
2023-09-19 | 10 percent owner |
Viking Global Investors Lp Latest Holdings Summary
Viking Global Investors Lp currently owns a total of 16 stocks. Among these stocks, Viking Global Investors Lp owns 40,765,599 shares of Myovant Sciences Ltd (MYOV) as of June 4, 2019, with a value of $1.1 Billion and a weighting of 21.8%. Viking Global Investors Lp owns 27,032,516 shares of APi Group Corp (APG) as of March 5, 2024, with a value of $977 Million and a weighting of 19.37%. Viking Global Investors Lp also owns 75,238,700 shares of Roivant Sciences Ltd (ROIV) as of June 22, 2023, with a value of $839 Million and a weighting of 16.63%. The other 13 stocks BridgeBio Pharma Inc (BBIO) , RayzeBio inc (RYZB) , Urovant Sciences Ltd (UROV) , Inhibrx Inc (INBX) , 4D Molecular Therapeutics Inc (FDMT) , Adaptive Biotechnologies Corp (ADPT) , FIGS Inc (FIGS) , Zentalis Pharmaceuticals Inc (ZNTL) , PROCEPT BioRobotics Corp (PRCT) , Frazier Lifesciences Acquisition Corp (FLAC) , Rallybio Corp (RLYB) , Sio Gene Therapies Inc (SIOX) , Amylyx Pharmaceuticals Inc (AMLX) have a combined weighting of 42.19% among all his current holdings.
Latest Holdings of Viking Global Investors Lp
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
MYOV | Myovant Sciences Ltd | 2019-06-04 | 40,765,599 | 26.98 | 1,099,855,861 |
APG | APi Group Corp | 2024-03-05 | 27,032,516 | 36.16 | 977,360,616 |
ROIV | Roivant Sciences Ltd | 2023-06-22 | 75,238,700 | 11.15 | 838,911,505 |
BBIO | BridgeBio Pharma Inc | 2023-07-18 | 25,120,991 | 28.48 | 715,445,824 |
RYZB | RayzeBio inc | 2023-09-19 | 6,642,700 | 62.49 | 415,102,323 |
UROV | Urovant Sciences Ltd | 2019-06-19 | 22,860,013 | 16.24 | 371,246,611 |
INBX | Inhibrx Inc | 2023-08-28 | 7,150,826 | 34.38 | 245,845,398 |
FDMT | 4D Molecular Therapeutics Inc | 2024-01-04 | 4,247,914 | 25.45 | 108,088,172 |
ADPT | Adaptive Biotechnologies Corp | 2020-12-14 | 29,993,708 | 3.43 | 102,728,450 |
FIGS | FIGS Inc | 2021-09-03 | 14,742,689 | 5.21 | 76,735,696 |
ZNTL | Zentalis Pharmaceuticals Inc | 2020-12-01 | 3,943,284 | 11.30 | 44,559,504 |
PRCT | PROCEPT BioRobotics Corp | 2022-03-18 | 298,205 | 67.85 | 20,233,209 |
FLAC | Frazier Lifesciences Acquisition Corp | 2022-11-02 | 1,211,582 | 9.87 | 11,958,314 |
RLYB | Rallybio Corp | 2021-07-29 | 4,194,777 | 1.64 | 6,879,434 |
SIOX | Sio Gene Therapies Inc | 2019-03-18 | 13,244,048 | 0.48 | 6,330,655 |
AMLX | Amylyx Pharmaceuticals Inc | 2022-09-09 | 1,850,940 | 1.79 | 3,313,183 |
Holding Weightings of Viking Global Investors Lp
Viking Global Investors Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, Viking Global Investors Lp has made a total of 1 transactions in Myovant Sciences Ltd (MYOV) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Myovant Sciences Ltd is the acquisition of 2,424,242 shares on June 4, 2019, which cost Viking Global Investors Lp around $20 Million.
According to the SEC Form 4 filings, Viking Global Investors Lp has made a total of 4 transactions in APi Group Corp (APG) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in APi Group Corp is the sale of 3,038,617 shares on March 5, 2024, which brought Viking Global Investors Lp around $104 Million.
According to the SEC Form 4 filings, Viking Global Investors Lp has made a total of 1 transactions in Roivant Sciences Ltd (ROIV) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Roivant Sciences Ltd is the sale of 13,000,000 shares on June 22, 2023, which brought Viking Global Investors Lp around $129 Million.
More details on Viking Global Investors Lp's insider transactions can be found in the Insider Trading History of Viking Global Investors Lp table.Insider Trading History of Viking Global Investors Lp
- 1
Viking Global Investors Lp Trading Performance
GuruFocus tracks the stock performance after each of Viking Global Investors Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Viking Global Investors Lp is 7.24%. GuruFocus also compares Viking Global Investors Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Viking Global Investors Lp within 3 months outperforms 17 times out of 28 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Viking Global Investors Lp's insider trading performs compared to the benchmark.
Performance of Viking Global Investors Lp
Viking Global Investors Lp Ownership Network
Ownership Network List of Viking Global Investors Lp
Ownership Network Relation of Viking Global Investors Lp
Viking Global Investors Lp Owned Company Details
What does Inhibrx Inc do?
Who are the key executives at Inhibrx Inc?
Viking Global Investors Lp is the 10 percent owner of Inhibrx Inc. Other key executives at Inhibrx Inc include 10 percent owner David C. Ott , 10 percent owner Viking Global Opportunities Parent Gp Llc , and 10 percent owner Rose Sharon Shabet .
Inhibrx Inc (INBX) Insider Trades Summary
Over the past 18 months, Viking Global Investors Lp made 1 insider transaction in Inhibrx Inc (INBX) with a net purchase of 511,627. Other recent insider transactions involving Inhibrx Inc (INBX) include a net sale of 120,000 shares made by Brendan P. Eckelman , a net sale of 52,060 shares made by Mark Lappe , and a net sale of 19,000 shares made by Jon Faiz Kayyem .
In summary, during the past 3 months, insiders sold 0 shares of Inhibrx Inc (INBX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 191,060 shares of Inhibrx Inc (INBX) were sold and 511,627 shares were bought by its insiders, resulting in a net purchase of 320,567 shares.
Inhibrx Inc (INBX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Inhibrx Inc Insider Transactions
Viking Global Investors Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Viking Global Investors Lp. You might contact Viking Global Investors Lp via mailing address: 600 Washington Blvd., Floor 11, Stamford Ct 06901.